ESWI Education Hub provides articles and links to important scientific papers, reviewed by the ESWI Board members, and other online educational activities

🔍Topics
🔍Medium
🔍Risk groups
🔍Networks
  1. Podcasts
    Intervention Strategies: Bonus Episode - Busting myths and restoring trust in vaccines
    What are the causes for the steady and at times dramatic decline in vaccine confidence seen since the mid-90’s across certain age-groups and communities? Why has the public discourse changed?
    Read more
  2. News,Scientific Papers
    The impact of highly pathogenic avian influenza H5N1 virus infection on dairy cows
    Highly pathogenic avian influenza (HPAI) H5N1 virus has been associated with severe mastitis in dairy cows, leading to decreased milk production.
    Read more
  3. News,Scientific Papers
    Purification and characterization of recombinant neuraminidase as a potentially broadly protective influenza virus vaccine candidate
    Influenza viruses pose a significant public health threat, causing seasonal epidemics and occasional pandemics with substantial morbidity and mortality worldwide.
    Read more
  4. News
    Global immunisation monitoring in times of drastic cutbacks
    Outbreaks of vaccine-preventable diseases are increasing at a time when funding for immunisation programmes is being cut.
    Read more
  5. News,Scientific Papers
    H5N1 preparedness must integrate rural and agricultural realities
    Successful implementation requires a more explicit focus: the social and infrastructural realities of rural agricultural communities where H5N1 risk is currently concentrated.
    Read more
  6. News,Scientific Papers
    Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage
    Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality.
    Read more
  7. News,Scientific Papers
    Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants
    Recombinant neuraminidase (NA) has emerged as an antigenically conserved intranasal vaccine candidate, capable of inducing broad cross-protection, but it requires effective mucosal adjuvants.
    Read more
  8. News,Scientific Papers
    Spatiotemporal reconstruction of the North American A(H5N1) outbreak reveals successive lineage replacements by descendant reassortants
    From this outbreak, we have sequenced 2955 complete A(H5N1) viral genomes from samples collected in Canada and, in conjunction with previously published data, performed multifaceted phylodynamic analyses.
    Read more
  9. News,Scientific Papers
    Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques
    Current vaccines for influenza rely on inactivated or live-attenuated viruses, which can be costly and time-consuming to produce.
    Read more
  10. News
    How governments influence public health research: a scoping review
    Governments can become involved in academic research to assist in public health decision-making. However, when governments become involved, the research process can be influenced away from academic research practices, jeopardizing research integrity.
    Read more
  11. News,Scientific Papers
    Susceptibility and shedding in Mx1+ and Mx1− female mice experimentally infected with dairy cattle A(H5N1) influenza viruses
    Clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) (HPAI H5N1) viruses have spread prolifically in dairy cattle in the US, resulting in dozens of human infections, some without well-established links to animal contacts.
    Read more
  12. News,Policy & Recommendations
    The European Commission launches a new strategy to make Europe a global leader in life sciences by 2030
    Life sciences drive innovation in medicine, food and sustainable production, adding nearly €1.5 trillion in value to the EU economy and supporting 29 million jobs across the European Union.
    Read more
  13. News,Scientific Papers
    Structural and functional characterization of the antigenicity of influenza A virus hemagglutinin subtype H15
    Avian H15 influenza viruses are closely related to H7 viruses, but feature a unique 9-amino acid insertion in their hemagglutinin head domain, creating an additional site for antigenic variation.
    Read more
  14. News,Scientific Papers
    Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1
    The findings suggest that the current H5N1 vaccine can elicit cross-neutralization of circulating H5N1 strains, if high antibody titers are achieved.
    Read more
  15. News,Scientific Papers
    Influenza at the human-animal interface: Summary and risk assessment, from 28 May to 1 July 2025
    From 28 May to 1 July 2025, based on reporting date, the detection of influenza A (H5N1) in nine humans, influenza A (H9N2) in three humans and influenza A(H10N3) in one human were reported officially.
    Read more
  16. News,Scientific Papers
    De novo design of D-peptide ligands: Application to influenza virus hemagglutinin
    Although D-peptides offer superior metabolic stability and immunogenicity properties compared to L-peptides, their discovery has been limited by current screening methods.
    Read more
  17. News,Scientific Papers
    New guidance document on zoonotic avian influenza prevention, preparedness and response published
    The Commission has published a guidance document on measures to prevent and respond to highly pathogenic avian influenza (HPAI) with potential zoonotic impact in animals other than birds.
    Read more
  18. Scientific Papers,News
    Considerations for use of avian influenza A(‎H5)‎ vaccines during the interpandemic and emergence periods: report of a WHO virtual scientific consultation, September 2024
    This report provides an overview of the landscape of A(H5) vaccines and summarizes options for Member States' potential use of A(H5) vaccination during the interpandemic and emergence periods.
    Read more
  19. News,Policy & Recommendations
    The fight against disinformation on health issues in the EU
    Croatia, Estonia, France, Germany, Lithuania, Slovenia and Spain produced an information note highlighting the loss of confidence in science and health authorities, representing a major challenge for democracies.
    Read more
  20. News,Scientific Papers
    Efficacy of baloxavir marboxil against bovine H5N1 virus in mice
    Since the first detection of highly pathogenic avian influenza H5N1 in U.S. dairy cattle in early 2024, the virus has spread rapidly, posing a major public health concern as the number of human cases continues to rise.
    Read more
  21. News,Scientific Papers
    Inactivation of Influenza A Viruses (H1N1, H5N1) During Grana-Type Raw Milk Cheesemaking: Implications for Foodborne Transmission Risk
    This study demonstrates that the traditional Grana-type cheese production process effectively inactivates both LPAIV and HPAIV, even at high contamination levels.
    Read more
  22. News,Scientific Papers
    Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood
    It is necessary to increase knowledge about the safety and effectiveness of influenza vaccination during pregnancy to improve awareness among patients and healthcare professionals and increase to increase vaccination coverage.
    Read more
  23. News,Scientific Papers
    Comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children over multiple influenza seasons (2019–2023)
    Annual vaccination with LAIV4 or IIV4 remains the best way to protect children against influenza infection.
    Read more
  24. News,Scientific Papers
    On the brink: H5N1 and the risk to human health
    The avian influenza virus is a pathogen that has been well known to the scientific community ever since its first detection in 1996.
    Read more